HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Busulphan is safe and efficient treatment in elderly patients with essential thrombocythemia.

AuthorsL Shvidel, E Sigler, M Haran, A Klepfish, A Duek, A Berrebi, M Shtalrid
JournalLeukemia (Leukemia) Vol. 21 Issue 9 Pg. 2071-2 (Sep 2007) ISSN: 0887-6924 [Print] England
PMID17611572 (Publication Type: Clinical Trial, Letter)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Busulfan
Topics
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating (administration & dosage, adverse effects, therapeutic use)
  • Busulfan (administration & dosage, adverse effects, therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Thrombocythemia, Essential (drug therapy)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: